Introduction
============

Animal models are essential to the study of infectious diseases in humans. In influenza research, several kinds of animals are used for this purpose ([@B2]; [@B20]; [@B32]). Among them, non-human primates (NHPs) are attractive due to their anatomical remembrance to humans and the availability of a variety of reagents. In fact, rhesus (*Macaca mulatta*) ([@B5]; [@B6]; [@B30]; [@B25]), cynomolgus (*Macaca fascicularis*) ([@B21], [@B22]; [@B14]; [@B3]; [@B9]; [@B29]; [@B18]; [@B15]; [@B24]; [@B11]; [@B19]; [@B31]), and pig-tailed (*Macaca nemestrina*) ([@B4]; [@B1]) macaques have all been used. Although seasonal human influenza viruses or low pathogenic avian influenza A(H7N9) viruses isolated from a patient replicate in the respiratory tract of macaques, these infected animals show mild or no clinical symptoms ([@B4]; [@B29]; [@B24]; [@B11]). Even upon infection with highly pathogenic avian influenza (HPAI) A(H5N1) or A(H7N9) viruses, which induce severe lesion in the respiratory tract of macaques, their clinical symptoms range from asymptomatic to mild ([@B6]; [@B25]; [@B18]; [@B8]; [@B28]) except for some severe ([@B21], [@B22]) or lethal cases ([@B3]; [@B18]; [@B31]). Similarly, although influenza A(H1N1)pdm09 viruses isolated in the early stage of the 2009 pandemic, which caused severe infections in humans and induced severe lung damage, the clinical symptoms of infected macaques ranged from asymptomatic ([@B9]; [@B10]; [@B27]; [@B15]) to mild ([@B23]; [@B17]). Thus, macaques do not necessarily mimic influenza in humans.

Another issue we need to consider in an animal model of influenza viruses is the inoculation route. Often, NHPs are inoculated with virus via a combination of the intratracheal, intranasal, ocular, and oral routes (i.e., the conventional route) ([@B9]; [@B29]; [@B18]). Clearly, delivering a highly concentrated virus-containing liquid to multiple sites in this way is different from an actual infection. Previously, we and others tested the aerosol route for influenza inoculation of cynomolgus macaques, and found it to be more effective than the conventional route ([@B15]; [@B31]; [@B28]). However, it is difficult to deliver an accurate amount of virus via the aerosol route. In contrast, the tracheal spray route can deliver precise liquid aerosol doses to the lung.

[@B16] showed that inoculation of the common marmoset (*Callithrix jacchus*) with A/California/07/2009 A(H1N1)pdm09 led not only to virus replication but also to human-like symptoms such as sneezing, nasal discharge, labored breathing, and lung damage. Similarly, [@B17] showed that common marmosets were susceptible to infection with A/Mexico/InDRE4487/2009 A(H1N1)pdm09. Some of their infected animals experienced labored breathing, loss of appetite, and one animal had persistent fast breathing and displayed tremors; however, none of these animals experienced sneezing, nasal discharge, coughing, or weight loss ([@B17]). In this study, we performed a comparative examination of the conventional route and the tracheal spray route of inoculation of marmosets with A(H1N1)pdm09 virus. We also investigated the susceptibility of marmosets to HPAI A(H5N1) virus to assess the possibility of using these animals as a non-human primate model for influenza research.

Materials and Methods {#s1}
=====================

Animals
-------

Common Marmosets (*C. jacchus*), free from *Salmonella*, *Shigella*, and *Yersinia*, were bred for this study at the Marmoset Research Department, Central Institute for Experimental Animals (Kawasaki, Japan). Three- to eight-year-old female marmosets (body weight, 295--403 g), were transferred to a biosafety level 3 facility at the University of Tokyo. One week before infection, each marmoset was moved into an isolation cage and placed in a separated isolator for acclimatization. Animals were provided wooden perches and a resting place made of wood as environmental enrichment, and were fed a balanced commercial primate diet (CMS-1M; CLEA Japan) supplemented with honey (Kato bihouen-honpo, Tokyo, Japan) and tap water *ad libitum*. The food was moistened with hot water to vary its texture. In addition to the standard diet, animals were fed sponge cake or marshmallows by animal caretakers. The room was maintained at a constant temperature (27°C) and relative humidity (50%) on a 12:12-h light/dark cycle. Therapeutic treatment with antibiotics and/or analgesics was not provided, because such treatment would have affected the experimental results. The research protocol used is in accordance with the Regulations for Animal Care of the University of Tokyo and the Guidelines for Proper Conduct of Animal Experiments by the Science Council of Japan, and was approved by the Animal Experiment Committee of the Institute of Medical Science, the University of Tokyo (approval number: PA14-30).

Cells and Viruses
-----------------

Madin-Darby canine kidney (MDCK) cells were maintained in Eagle's minimal essential medium (MEM) containing 5% newborn calf serum at 37°C in 5% CO~2~. Human pandemic A(H1N1) virus A/Osaka/164/2009 (Osaka164) ([@B9]) and highly pathogenic A(H5N1) virus A/Vietnam/1203/2004 (VN1203) ([@B18]) were propagated in MDCK cells with MEM containing 0.3% bovine serum albumin (BSA).

Plaque Assay
------------

Viruses were diluted in MEM containing 0.3% BSA. Confluent monolayers of MDCK cells were washed with MEM containing 0.3% BSA, infected with diluted viruses, and incubated for 30--60 min at 37°C. After the virus inoculum was removed, the cells were washed with MEM containing 0.3% BSA and overlaid with a 1:1 mixture of 2× MEM/0.6% BSA and 2% agarose containing 1 μg/ml tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin. Plates were incubated at 37°C for 48 h before virus plaques were counted.

Experimental Infection of Marmosets With A/Osaka/194/2009 \[Osaka164: A(H1N1)pdm09\]
------------------------------------------------------------------------------------

Under anesthesia with isoflurane, four animals were inoculated with 1.0 × 10^7^ PFU (in 200 μl) of Osaka164 (pdmH1N1) either via the tracheal spray route with a MicroSprayer^®^ Aerosolizer (liquid) -- Model IA-1B (Penn-Century, Inc., Wyndmoor, PA, United States) or via a combination of the intratracheal (100 μl), intranasal (20 μl per nostril), ocular (10 μl per eye), and oral (40 μl) routes. To administer sufficient amounts of virus, we infected the animals with a high dose of virus (1.0 × 10^7^ PFU). We observed the marmosets twice daily, once in the morning and once in the evening, during the experiment to monitor their clinical symptoms. Every other day, the body weight and temperature of each marmoset was measured, nasal aspirates were collected for virus titration, and the animals' respiratory organs were scanned by means of micro-CT (Rigaku Corporation, Japan) until 15 days post-infection (dpi). Body temperature were measured in the rectum without anesthesia; other treatments were performed under anesthesia with isoflurane.

Experimental Infection of Marmosets With A/Vietnam/1203/2004 \[VN1203: A(H5N1)\]
--------------------------------------------------------------------------------

Under anesthesia with isoflurane, seven animals were inoculated with 1.0 × 10^7^ PFU (in 200 μl) of VN1203 A(H5N1) via the tracheal spray route. We observed the marmosets twice daily, once in the morning and once in the evening, during the experiment to monitor their clinical symptoms. Every other day, the body weight and temperature of each marmoset was measured, and nasal aspirates were collected for virus titration. Three or four marmosets were euthanized on 3 or 6 dpi, respectively, and their organs were collected (lungs, bronchus, trachea, nasal turbinate, heart, liver, spleen, kidney, duodenum, rectum, and tonsil), and homogenized with MEM containing 0.3% BSA. Virus titers in these homogenized organs were determined by use of plaque assays in MDCK cells.

Pathological Examination
------------------------

Excised tissues were fixed in 4% paraformaldehyde phosphate (PFA) buffer solution for 48 h and processed for paraffin embedding. Nasal samples were immersed in EDTA solution for decalcification after being fixed in PFA. The paraffin blocks were cut into 3-μm-thick sections and were mounted on silane-coated glass slides. To detect sialic acid linked to galactose by an α-2,6 linkage (SAα2,6Gal) or an α-2,3 linkage (SAα2,3Gal), the sections were pre-treated with 0.05% trypsin (DIFCO Laboratories, Detroit, MI, United States) at 37°C for 15 min and with 0.3% hydrogen peroxide at room temperature for 30 min. Then, they were incubated at 4°C, overnight with biotin-conjugated *Sambucus nigra* lectin I (SNA I; EY Laboratories) for SAα2,6Gal detection or biotinylated *Maackia amurensis* Lectin II (MAA II; Vector Laboratories) for SAα2,3Gal detection. After being washed, the sections were incubated with HRP-conjugated streptavidin and were visualized by staining with 3,3′-diaminobenzidine (DAB). The sections were also stained using a standard hematoxylin and eosin procedure and each serial section was processed for immunohistochemistry with a mouse monoclonal antibody for type A influenza nucleoprotein antigen (prepared in our laboratory) that reacts comparably with both of the viruses used in this study. Specific antigen--antibody reactions were visualized with DAB staining by using the DAKO Envision system (DAKO Cytomation).

Results
=======

Distribution of Sialic Acids in the Respiratory Tract of a Marmoset
-------------------------------------------------------------------

First, we examined the sialyloligosaccharide distribution in the respiratory tract of a 5-year-old female marmoset. In the nasal turbinate, pharynx, trachea, bronchus, bronchiole, and alveolus, none of the sections reacted with SNA I, which is specific for SAα2,6Gal (**Figures [1A](#F1){ref-type="fig"}--[E](#F1){ref-type="fig"}**, center). In contrast, epithelial cells that bind SAα2,3Gal-specific MAA II were detected in the nasal turbinate, trachea, bronchus, bronchiole, and alveolus (**Figures [1A,C--E](#F1){ref-type="fig"}**, right).

![Detection of SAα2,6Gal and SAα2,3Gal oligosaccharides in the nasal turbinate **(A)**, pharynx **(B)**, trachea **(C)**, bronchus **(D)**, and bronchiole/alveolar **(E)** of a 5-year-old marmoset. No section reacted with SNA I (**A--E**, center). In contrast, MAA II reacted with epithelial cells in the nasal turbinate, trachea, bronchus, bronchiole, and alveolus (**A**,**C--E**, right). Quantification of MAA II-positive cells in each section: none (--), a few (+), several and partial (2+), many and diffuse (3+).](fmicb-09-00844-g001){#F1}

Comparison of Influenza Virus Inoculation Routes
------------------------------------------------

We next performed a pilot study using a limited number of animals to determine a suitable inoculation route by comparing inoculation with Osaka164 A(H1N1)pdm09 virus (1.0 × 10^7^ PFU/200 μl/animal) via two routes: the tracheal spray route (200 μl), and the conventional route, which is a combination of the intratracheal (100 μl), intranasal (20 μl per nostril), ocular (10 μl per eye), and oral (40 μl) routes. Four 4- to 8-year-old female marmosets were intramuscularly anesthetized and intratracheally inoculated via the tracheal spray route (*n* = 2, animal IDs: CJ03 and CJ04) or via the conventional route (*n* = 2, animal IDs: CJ05 and CJ06). None of the infected marmosets showed any clinical signs or changes in body weight or temperature (data not shown). One of the animals inoculated via the tracheal spray route and both animals inoculated via the conventional route shed virus from their nasal cavity until 7 or 11 dpi, respectively, (**Table [1](#T1){ref-type="table"}**). We also scanned the whole lungs of the animals every other day by using micro-CT. Inflammation in CJ04 was spread throughout the lung and trachea on 3 dpi (**Figure [2](#F2){ref-type="fig"}**, left), whereas inflammation in CJ06 was confined to around the center of the lung (**Figure [2](#F2){ref-type="fig"}**, right). These data suggest that the tracheal spray can evenly deliver virus to a wider area of lungs than the conventional method.

###### 

Virus titers in the nasal aspirate of marmosets infected with Osaka164^a^.

  Inoculation route      Animal ID   Virus titers (log~10~PFU/ml)                                 
  ---------------------- ----------- ------------------------------ ----- ----- ----- ----- ----- ----
  Tracheal spray route   CJ03        --                             --    --    --    --    --    --
                         CJ04        1.4                            4.7   --    3.2   --    --    --
  Conventional route     CJ05        1.0                            1.8   2.1   --    5.2   1.3   --
                         CJ06        1.6                            3.7   2.8   2.4   --    --    --
                                                                                                  

a

Four- to eight-year-old female marmosets were anesthetized and inoculated with 1.0 × 10

7

PFU (in 200 μl) of Osaka164 via the tracheal spray route (CJ03 and CJ04) or via the conventional route (CJ05 and CJ06). Under anesthesia, nasal aspirates from each marmoset were collected every other day for virus titration.

![Micro-CT of VN1203-infected marmosets. CJ04 was infected via the tracheal spray route; CJ06 was infected via the conventional route. Images of the lungs of marmosets CJ04 and CJ06 on 3 dpi. The pink color indicates inflamed areas.](fmicb-09-00844-g002){#F2}

Growth Properties of A(H5N1) Virus in Marmosets
-----------------------------------------------

To evaluate the suitability of the marmoset model for the study of HPAI virus infection, 3- to 7-year-old female marmosets were anesthetized and inoculated with 1.0 × 10^7^ PFU of VN1203 A(H5N1) virus (*n* = 7, animal IDs CJ07, CJ09--14) via the tracheal spray route. Two animals (CJ07 and CJ10) showed sudden weight loss after 1 dpi, and two other animals (CJ12 and CJ14) showed moderate weight loss during the observation period (**Figure [3A](#F3){ref-type="fig"}**). Three animals on 1 dpi (CJ07, CJ10, and CJ14) and one animal on 3 dpi (CJ12) showed decreased body temperature, but the temperature of all four animals returned to normal on the next measuring date (**Figure [3B](#F3){ref-type="fig"}**). CJ07 and CJ14 showed loss of appetite and reduced activity from 2 dpi to the final day of the observation period, but they did not cough or sneeze (data not shown). On 3 (*n* = 3; CJ07, CJ09, and CJ10) and 6 (*n* = 4; CJ11, CJ12, CJ13, and CJ14) dpi, animals were euthanized and their organs were collected for virological and pathological examination. High titers of VN1203 were detected in all of the respiratory organs and other internal organs on 3 dpi although at this time point, the virus was recovered from only the cerebellum of one animal (**Table [2](#T2){ref-type="table"}**). By 6 dpi, the virus titers had declined in many organs; however, the virus was recovered from all parts of the brain of one animal (CJ14). Although there was some variability among the virus titers, as is commonly observed among outbred animals, these results indicate that marmosets are susceptible to A(H5N1) virus.

![Change in body weight **(A)** and body temperature **(B)** of VN1203-infected marmosets. On 0 (the day of infection), 1, 3, 5, and 6 dpi, the body weight **(A)** and temperature **(B)** of each marmoset was measured. Three (CJ07, CJ09, and CJ10) or four (CJ11, CJ12, CJ13, and CJ14) marmosets were euthanized on 3 or 6 dpi, respectively.](fmicb-09-00844-g003){#F3}

###### 

Virus titers in organs of infected marmosets^a^.

  Organs                        Virus titers (log~10~PFU/g)                                   
  ----------------- ----------- ----------------------------- ----- ----- ------- ----- ----- -----
  Left lung         Cranial     7.2                           3.3   6.7   --^b^   --    3.2   --
                                                                                              
                                                                                              
                    Caudal      6.2                           3.9   6.6   --      --    2.9   --
                                                                                              
                                                                                              
  Right lung        Cranial     6.7                           4.1   6.8   --      3.7   3.9   --
                                                                                              
                                                                                              
                    Middle      7.6                           5.5   5.6   --      2.7   2.7   --
                                                                                              
                                                                                              
                    Caudal      8.0                           4.0   6.2   --      4.3   2.7   --
                                                                                              
                                                                                              
                    Accessary   7.3                           3.7   6.5   --      --    --    --
                                                                                              
                                                                                              
  Trachea                       5.6                           3.4   4.7   --      6.0   2.4   3.0
                                                                                              
                                                                                              
  Left bronchus                 7.7                           3.2   6.9   --      3.3   5.0   3.4
                                                                                              
                                                                                              
  Nasal turbinate               6.1                           5.7   4.6   5.3     --    6.5   4.4
                                                                                              
                                                                                              
  Cerebrum          Frontal     --                            --    --    --      --    --    3.0
                                                                                              
                                                                                              
                    Temporal    --                            --    --    --      --    --    3.2
                                                                                              
                                                                                              
                    Parietal    --                            --    --    --      --    --    3.3
                                                                                              
                                                                                              
                    Occipital   --                            --    --    --      --    --    4.4
                                                                                              
                                                                                              
  Brain stem                    --                            --    --    --      --    --    6.8
                                                                                              
                                                                                              
  Olfactory bulb                --                            --    --    --      --    --    4.9
                                                                                              
                                                                                              
  Cerebellum                    4.5                           --    --    --      --    3.7   5.1
                                                                                              
                                                                                              
  Heart                         4.2                           3.4   3.6   --      --    --    --
                                                                                              
                                                                                              
  Liver                         4.7                           --    3.2   --      --    --    --
                                                                                              
                                                                                              
  Duodenum                      4.6                           4.5   4.0   --      --    --    --
                                                                                              
                                                                                              
  Colon                         4.2                           --    6.0   --      --    --    2.0
                                                                                              
                                                                                              
  Spleen                        3.8                           --    4.1   --      --    2.7   --
                                                                                              
                                                                                              
  Kidney                        4.2                           --    2.2   --      --    --    --
                                                                                              
                                                                                              
  Serum                         --                            --    --    --      --    --    --
                                                                                              
                                                                                              
  Whole blood                   ND^c^                         ND    ND    --      --    --    --
                                                                                              
                                                                                              
                                                                                              

a

Marmosets were inoculated with 1.0 × 10

7

PFU (in 200 μl) of VN1203 A(H5N1) via the tracheal spray route;

b

--, virus not detected (detection limit: 1.0 log

10

PFU/ml);

c

ND, not done.

Pathological Analyses of A(H5N1) Virus-Infected Marmosets
---------------------------------------------------------

The distribution of antigen-positive cells detected by immunohistochemistry (**Tables [3A,B](#T3A){ref-type="table"}**) showed almost the same pattern as that of the virus titers (**Table [2](#T2){ref-type="table"}**). Viral antigen was detected in the nasal turbinate and trachea in both the 3 and 6 dpi groups (**Figures [4A,B](#F4){ref-type="fig"}** and **Table [3A](#T3A){ref-type="table"}**). All lung sections showed inflammation, and the viral antigen-positive signal was more widely observed in CJ07 and CJ10 than the other animals (**Figure [4C](#F4){ref-type="fig"}** and **Table [3A](#T3A){ref-type="table"}**). Some of the heart and liver samples showed focal inflammation as well as viral antigen-positive cells (**Figures [4D,E](#F4){ref-type="fig"}** and **Table [3B](#T3B){ref-type="table"}**). In the brain, only a few sections showed mild focal inflammation; however, immunohistochemistry revealed some neural cells that were positive for viral antigen, particularly many ependymal cells in CJ14 (**Figure [5](#F5){ref-type="fig"}** and **Table [3B](#T3B){ref-type="table"}**). These findings indicate that VN1203 infected and replicated not only in the respiratory organs but also in the heart, liver, and brain of marmosets.

###### 

Pathologic scores^a,b^ of respiratory organs by hematoxylin and eosin staining (HE) and the number of antigen-positive cells^c^ by immunohistochemistry (IHC) in VN1203-infected marmosets.

  Organs                        3 dpi   6 dpi                                                             
  ----------------- ----------- ------- ------- ---- ---- ---- ---- ---- ------- ---- ---- ---- ---- ---- ----
  Left lung         Cranial     4       \+      3    \-   5    \+   4    \-^b^   4    \-   5    \-   3    \-
                                                                                                          
                                                                                                          
                    Caudal      4       \+      3    \-   5    \+   3    \-      4    \-   5    \-   4    \-
                                                                                                          
                                                                                                          
  Right lung        Cranial     4       \+      3    \-   5    \+   3    \-      5    \+   4    \+   5    \-
                                                                                                          
                                                                                                          
                    Middle      4       \+      3    \-   4    \+   3    \-      5    \-   5    \+   4    \-
                                                                                                          
                                                                                                          
                    Caudal      3       \+      3    \-   5    \+   3    \-      5    \-   5    \-   5    \-
                                                                                                          
                                                                                                          
                    Accessary   NA^d^   NA      NA   NA   NA   NA   NA   NA      NA   NA   NA   NA   NA   NA
                                                                                                          
                                                                                                          
  Trachea                       1       \+      1    \-   1    \-   1    \-      1    \+   1    \-   1    \+
                                                                                                          
                                                                                                          
  Nasal turbinate               1       \+      1    \+   2    \+   1    \+      1    \-   1    \+   1    \+
                                                                                                          
                                                                                                          
                                                                                                          

a

Lung: -, no apparent changes; 1, minimal changes; 2, slight inflammation; 3, mild inflammation including infiltration of neutrophils, monocytes/macrophages, or lymphocytes; 4, moderate inflammation (\>50% of sections examined); 5, marked inflammation including edema and fibrin transudation. The area with edema and fibrin transudation represents \<50% of the section examined; 6, severe inflammation. The area with edema and fibrin transudation represents \>50% of the section examined.

b

Trachea and nasal turbinate: -, no apparent changes; 1, mild inflammation; 2, moderate inflammation; 3, severe inflammation.

c

Detection of influenza virus antigen in tissue sample sections. The extent of the abundance of virus-antigen-positive cells in the entire section of the sample was defined as follows: -, no antigen-positive cells found; +, 1--10 virus-antigen-positive cells found; ++, 11--101 virus-antigen-positive cells found; +++, \> 101 virus-antigen-positive cells found.

d

NA, not available.

![Pathological examination of the nasal turbinate **(A)**, trachea **(B)**, lung **(C)**, heart **(D)**, and liver **(E)** of VN1203-infected marmosets. a, b, m, n, CJ09; c, d, s, t, CJ11; e, f, i, j, q, r, CJ07; g, h, CJ14; k, l, CJ13; o, p, CJ12. Red arrows in (l) indicate antigen-positive cells. HE, hematoxylin and eosin staining; IHC, immunohistochemistry for the detection of influenza virus NP antigen.](fmicb-09-00844-g004){#F4}

###### 

Pathologic scores^a^ of non-respiratory organs by hematoxylin and eosin staining (HE) and the number of antigen-positive cells^b^ by immunohistochemistry (IHC) in VN1203-infected marmosets.

  Organs                       3 dpi   6 dpi                                                             
  ---------------- ----------- ------- ------- ---- ---- ------- ---- ---- ---- ---- ---- ---- ---- ---- -----
  Cerebrum         Frontal     \-      \-      \-   \-   \-      \-   \-   \-   \-   \-   \-   \-   \-   +++
                   Temporal    \-      \-      \-   \-   \-      \-   \-   \-   \-   \+   \-   \+   \-   +++
                   Parietal    \-      \+      \-   \-   1       \-   \-   \-   \-   \-   \-   \-   \-   +++
                   Occipital   \-      \+      \-   \-   \-      \-   \-   \-   \-   \-   \-   \-   \-   ++
  Brain stem                   \-      \-      \-   \-   \-      \-   \-   \-   1    \+   1    \+   \-   +++
  Olfactory bulb               \-      \-      \-   \-   NA^c^   NA   \-   \-   \-   \-   \-   \-   \-   \-
  Cerebellum                   \-      \+      \-   \-   \-      \-   \-   \-   \-   \-   \-   \+   \-   \-
  Heart                        \-      ++      1    ++   \-      \+   \-   \-   1    \+   \-   \+   \-   NA
  Liver                        1       ++      \-   \-   1       \+   1    \-   \-   \-   \-   \-   \-   \-
  Duodenum                     \-      \-      \-   \-   \-      \-   \-   \-   \-   \-   NA   NA   NA   NA
  Colon                        \-      \-      \-   \-   \-      \-   \-   \-   \-   \-   \-   \-   \-   \-
  Spleen                       \-      \-      \-   \-   \-      \-   \-   \-   \-   \-   \-   \-   \-   NA
  Kidney                       \-      \-      \-   \-   \-      \-   \-   \-   \-   \-   \-   \-   \-   \-
                                                                                                         

a

-, No apparent changes; 1, mild inflammation; 2, moderate inflammation; 3, severe inflammation.

b

Detection of influenza virus antigen in tissue sample sections. The extent of the abundance of virus-antigen-positive cells in the entire section of the sample was defined as follows: -, no antigen-positive cells found; +, 1--10 virus-antigen-positive cells found; ++, 11--101 virus-antigen-positive cells found; +++, \> 101 virus-antigen-positive cells found.

c

NA, not available.

![Pathological examination of marmoset brain. Cerebrum of CJ07 **(A)**, cerebrum of CJ14 **(B)**, hippocampus of CJ14 **(C)**, brain stem of CJ13 **(D)**, and cerebellum of CJ13 **(E)**, which were infected with VN1203. Black arrows in **(B)** indicate ependyma. HE, hematoxylin and eosin staining; IHC, immunohistochemistry for the detection of influenza virus NP antigen.](fmicb-09-00844-g005){#F5}

Discussion
==========

[@B16] showed that marmosets infected with A/California/07/2009 A(H1N1)pdm09 virus via the conventional route (a combination of intratracheal, oral, intranasal, and ocular inoculation) supported replication of the virus, and exhibited symptoms commonly seen in humans, including sneezing, nasal discharge, and labored breathing ([@B16]). [@B17] similarly found that marmosets infected with A/Mexico/InDRE4487/2009 A(H1N1)pdm09 virus via the intratracheal route (using a catheter inserted into the trachea) supported replication of the virus, and displayed labored breathing and loss of appetite but did not experience sneezing, nasal discharge, or coughing. In contrast, in our study, we found that a different A(H1N1)pdm09 strain (Osaka164) did not cause any symptoms in marmosets infected via either the conventional or intratracheal spray route although this virus caused clear respiratory symptoms (e.g., sneezing) in ferrets ([@B12]). This difference in tissue tropism likely reflects the difference in the virus strains used. Although we could not reproduce the previous finding of clinical symptoms in this animal species with an A(H1N1)pdm09 strain, our findings indicate that marmosets are highly sensitive to this virus.

VN1203 A(H5N1)-infected marmosets showed symptoms such as loss of appetite and reduced activity but not respiratory symptoms such as sneezing, nasal discharge, or labored breathing. However, virus replication was observed not only in the respiratory tract of the marmosets but also other organs including brain and heart (**Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}** and **Tables [2](#T2){ref-type="table"}**, **[3B](#T3B){ref-type="table"}**). Previous studies of A(H5N1)-infected patients have detected A(H5N1) viruses outside the respiratory tract in brains, intestines, spleen, and circulating mononuclear cells ([@B26]; [@B7]). [@B21] found that A/Hong Kong/156/97 (H5N1) replicated not only in the respiratory tract but also in the heart of cynomolgus macaques. In our previous study of cynomolgus macaques infected with A/Vietnam/UT3040/2004 \[H5N1; note that A/Vietnam/UT3040/2004(H5N1) and VN1203 were isolated from the same patient and their pathogenicity in animal models is similar ([@B13])\], we readily detected virus in the respiratory organs and conjunctiva, but not in other systemic organs, ([@B18]), and we detected virus in only a portion of the brain (only in the occipital lobe of 1 of 6 animals), in the duodenum (1 of 6 animals), and in the mediastinal lymph node (3 of 6 animals) ([@B28]). In this study, VN1203 A(H5N1) virus replicated in various organs of marmoset (**Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}** and **Tables [2](#T2){ref-type="table"}**, **[3B](#T3B){ref-type="table"}**). This result suggests that marmosets are more susceptible to VN1203 A(H5N1) than are cynomolgus macaques.

In this study, we tested the tracheal spray route as a novel infection route. Previously, we found that the conventional infection route results in rather localized replication of influenza viruses in the lungs of rhesus ([@B25]) and cynomolgus macaques ([@B9]; [@B29]; [@B18]; [@B11]). Similarly, in the present study, inoculation via the conventional route led to a strong local infection (**Figure [2](#F2){ref-type="fig"}**). In contrast, inoculation via the tracheal spray route led to virus replication throughout the lung (**Figure [2](#F2){ref-type="fig"}**). A(H5N1) infection via the tracheal spray route produced only limited variations in the pathologic scores for the lung lobes of each animal (**Table [3A](#T3A){ref-type="table"}**). These results suggest that the tracheal spray route better represented an actual infection than did the conventional route. In this study, 1 of 2 (50%) animals infected via the tracheal spray route did not shed virus, whereas 2 of 2 (100%) animals inoculated via the conventional route shed virus (**Table [1](#T1){ref-type="table"}**). Similarly, in our cynomolgus macaque experiments, we found that 1 of 4 (25%) of the animals infected via the aerosol route did not shed virus, whereas 3 of 3 (100%) animals infected via the conventional route shed virus ([@B28]). Since virus is directly inoculated into the nostril by the conventional route, it would be easier for the virus to replicate and be detected at the inoculation site by nasal swabbing than when the aerosol or tracheal spray route is used. Virus replication in CJ03 (**Table [1](#T1){ref-type="table"}**) and CJ11 (**Table [2](#T2){ref-type="table"}**), which were infected via the tracheal spray route, was limited, which may have been due to technical issues with the virus administration. Alternatively, these animals may have been immune to influenza viruses, although we screened the animals to ensure that they lacked neutralizing antibodies against influenza viruses before we infected them. Some variability in virus titers among individual animals has been reported previously with outbred animal models ([@B21]; [@B18]; [@B28]). Although further adjustment may be needed to optimize the tracheal spray route as a method of inoculation (e.g., determining the optimal depth of insertion of the spray, inoculum volume, etc.), this route appears to be suitable as an alternative approach to influenza virus inoculation.

By using SNAI and MAAII lectin staining, we found that only SAα2,3Gal was detectable in the respiratory tract of the marmoset; SAα2,6Gal was not detected (**Figure [1](#F1){ref-type="fig"}**). Yet, high replication of VN1203 A(H5N1) human virus, which preferentially binds to SAα2,6Gal over SAα2,3Gal, was observed in respiratory tissues (**Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}** and **Tables [2](#T2){ref-type="table"}**, **[3](#T3A){ref-type="table"}**). These findings may suggest that the SAα2,6Gal that is present in the respiratory tract of marmoset is not detectable with SNAI. Further studies are needed to test this possibility.

One limitation of our study, and all NHP studies, is that the number of animals used must be small for ethical reasons. Despite these small numbers, however, valuable information can be obtained; for example, extensive immunological studies are possible due to the availability of abundant immunological reagents. In conclusion, our data show that marmosets can be used in influenza research for pathogenicity studies and also live imaging by micro-CT. Marmosets have potential as a primate model for studies of human and HPAI virus infection.
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